GTEX-1H2FU
|
61-70
|
Female
|
GTEX-1H2FU-1226 |
Lung
|
PAXgene |
2
|
2 pieces; congestion and some intra-alveolar hemorrhage
|
Acceptable
|
|
GTEX-1H3NZ
|
61-70
|
Male
|
GTEX-1H3NZ-0826 |
Lung
|
PAXgene |
1
|
2 pieces; moderate diffuse fibrosis, emphysema
|
Acceptable
|
|
GTEX-1H3O1
|
51-60
|
Male
|
GTEX-1H3O1-0326 |
Lung
|
PAXgene |
1
|
2 pieces, marked congestion & atalectasis
|
Acceptable
|
|
GTEX-1H3VE
|
41-50
|
Male
|
GTEX-1H3VE-1026 |
Lung
|
PAXgene |
2
|
2 pieces; marked congestion
|
Acceptable
|
|
GTEX-1H3VY
|
51-60
|
Male
|
GTEX-1H3VY-1426 |
Lung
|
PAXgene |
0
|
2 pieces; includes pleura (target is 1cm below pleura), collapse and some emphysematous change, pneumonia
|
Acceptable
|
|
GTEX-1H4P4
|
51-60
|
Male
|
GTEX-1H4P4-0126 |
Lung
|
PAXgene |
2
|
2 pieces; collapse, some fibrosis, pulmonary macrophages, some congestion, sloughed bronchial epithelium
|
Acceptable
|
|
GTEX-1HB9E
|
51-60
|
Male
|
GTEX-1HB9E-0726 |
Lung
|
PAXgene |
1
|
2 pieces, chronic interstitial pneumonitis with fibrosis and hyaline membrane formation, chronic injury pattern
|
Acceptable
|
|
GTEX-1HBPH
|
41-50
|
Female
|
GTEX-1HBPH-1326 |
Lung
|
PAXgene |
1
|
2 pieces; patchy pulmonary edema
|
Acceptable
|
|
GTEX-1HBPI
|
41-50
|
Male
|
GTEX-1HBPI-0926 |
Lung
|
PAXgene |
1
|
2 pieces; moderate interstitial fibrosis; numerous alveolar macrophages and desquamated alveolar lining cells
|
Acceptable
|
|
GTEX-1HBPM
|
61-70
|
Female
|
GTEX-1HBPM-0826 |
Lung
|
PAXgene |
1
|
2 pieces; some congestion, anthracotic pigment, some fibrosis and pigmented macrophages, widening of airspaces
|
Acceptable
|
|
GTEX-1HBPN
|
51-60
|
Male
|
GTEX-1HBPN-1126 |
Lung
|
PAXgene |
1
|
2 pieces diffuse interstitial mixed inflammation and acute/purulent bronchoitis/bronchioliits. Reviewed by NIH consult panel.
|
Unacceptable
|
|
GTEX-1HC8U
|
41-50
|
Female
|
GTEX-1HC8U-0426 |
Lung
|
PAXgene |
1
|
2 pieces; extensive interstitial fibrosis; several foci of bronchopneumonia; <30% is relatively undamaged lung
|
Unacceptable
|
|
GTEX-1HCU6
|
61-70
|
Female
|
GTEX-1HCU6-0826 |
Lung
|
PAXgene |
2
|
2 pieces; pigmented alveolar macrophages, patchy interstitial fibrosis; focal alveolar hemorrhage
|
Acceptable
|
|
GTEX-1HCU7
|
51-60
|
Male
|
GTEX-1HCU7-0926 |
Lung
|
PAXgene |
2
|
2 pieces; patchy pneumonia; numerous intraalveolar pigmented macrophages; mild to moderate interstitial fibrosis
|
Acceptable
|
|
GTEX-1HCU8
|
61-70
|
Female
|
GTEX-1HCU8-0826 |
Lung
|
PAXgene |
1
|
2 pieces, moderate/marked congestions/edema/ diffuse alveolar damage
|
Acceptable
|
|
GTEX-1HCUA
|
51-60
|
Female
|
GTEX-1HCUA-0226 |
Lung
|
PAXgene |
0
|
2 pieces; some collapse, pigmented macrophages
|
Acceptable
|
|
GTEX-1HCVE
|
51-60
|
Male
|
GTEX-1HCVE-0626 |
Lung
|
PAXgene |
1
|
2 pieces, moderate congestion
|
Acceptable
|
|
GTEX-1HFI6
|
41-50
|
Male
|
GTEX-1HFI6-0926 |
Lung
|
PAXgene |
1
|
2 pieces, atalectasis, interstitial fibrosis/patchy hyaline membrane formation suggests component of diffuse alveolar damage
|
Acceptable
|
|
GTEX-1HGF4
|
61-70
|
Male
|
GTEX-1HGF4-0626 |
Lung
|
PAXgene |
1
|
2 pieces; pulmonary edema with alveolar macrophages; moderate congestion
|
Acceptable
|
|
GTEX-1HKZK
|
21-40
|
Male
|
GTEX-1HKZK-0926 |
Lung
|
PAXgene |
1
|
2 pieces; extensive pneumonia
|
Unacceptable
|
|
GTEX-1HR98
|
61-70
|
Male
|
GTEX-1HR98-1826 |
Lung
|
PAXgene |
2
|
2 pieces; patchy moderate interstitial fibrosis; moderate alveolar edema
|
Acceptable
|
|
GTEX-1HR9M
|
61-70
|
Male
|
GTEX-1HR9M-0826 |
Lung
|
PAXgene |
2
|
2 pieces; severe arterial hypertrophy [labeled] with interstitial fibrosis consistent with clinical history of pulmonary scleroderma
|
Acceptable
|
|
GTEX-1HSEH
|
61-70
|
Male
|
GTEX-1HSEH-0926 |
Lung
|
PAXgene |
1
|
2 pieces, advanced interstitial fibrosis, end-stage
|
Unacceptable
|
|
GTEX-1HSKV
|
61-70
|
Male
|
GTEX-1HSKV-1126 |
Lung
|
PAXgene |
1
|
2 pieces; includes pleura (target is 1cm below pleura, some widened air spaces
|
Acceptable
|
|
GTEX-1HSMO
|
61-70
|
Male
|
GTEX-1HSMO-0926 |
Lung
|
PAXgene |
2
|
2 pieces; severe interstitial fibrosis (correlates with clinical diagnosis); may be of limited use
|
Acceptable
|
|